Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma

[TimAlerts] GBT http://finance.yahoo.com/news/global-blood-therapeutics-announces-pivotal-200500928.html Global Blood Therapeutics Announces Pivotal Study for GBT440 in Sickle Cell Disease with Primary Hemoglobin Endpoint
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma



